- Summits
- Sponsorship
- Media Opportunities
- News
- About
As Florida moves closer to its 2026 legislative session, healthcare and life sciences are emerging as clear funding priorities, not just in rhetoric, but in real dollars. Governor Ron DeSantis’ proposed $117.36 billion “Floridians First” budget, released ahead of the January 13 session deadline, outlines targeted investments aimed at accelerating research, improving patient access, and strengthening the state’s health innovation ecosystem.
The budget reflects a deliberate focus on areas where policy, funding, and innovation intersect, particularly oncology, rare diseases, and workforce-driven growth. A $10 million increase brings the Cancer Connect Collaborative Research Incubator to $40 million, with an initial emphasis on pediatric cancer, signalling a push to support collaborative research models and faster translation from lab to clinic.
The proposal allocates $60 million through the Florida Cancer Innovation Fund, alongside $10 million in new funding to establish the Casey DeSantis Cancer Innovation, Care, and Research Program, an initiative aimed at strengthening research, care delivery, and statewide coordination.
Beyond oncology, the budget includes $10 million dedicated to sickle cell treatment and research, addressing a historically underserved patient population, while $50 million for the Job Growth Grant Fund underscores Florida’s intent to attract companies, scale innovation-driven businesses, and support workforce expansion across high-growth sectors, including MedTech and digital health.
Taken together, these investments point to a state that is not only funding healthcare services, but actively shaping an environment where research, commercialization, and company growth are encouraged, creating timely relevance for MedTech leaders looking to engage with the U.S. market.
It is against this backdrop that MedTech World North America arrives in Florida.
From May 11 to 13, MedTech World will host MedTech World North America at the Hilton West Palm Beach, marking the organisation’s first flagship event in the United States.
The Florida edition builds on the momentum of MedTech World North America earlier this year in San Jose, organised in partnership with MedTech Innovator, where startups, investors, corporates, and healthcare leaders came together to discuss commercialization pathways, regulatory realities, and capital formation.
West Palm Beach now offers a different but highly complementary setting:
Florida’s proposed budget highlights clear opportunity areas for MedTech companies working in:
MedTech World North America is designed as a meeting point where these priorities intersect with real-world execution—bringing together founders, investors, clinicians, regulators, and industry leaders who are shaping what comes next.
As MedTech World North America takes shape, opportunities are now open for:
Whether you are scaling into the U.S. market, building partnerships in Florida, or exploring funding and clinical pathways, the event is structured to support meaningful connections, not just conversations.
With Florida increasing its commitment to healthcare innovation and MedTech World bringing its flagship U.S. event to West Palm Beach, May 2026 offers a timely moment to engage with the North American MedTech ecosystem.
Registration of interest is now open for MedTech World North America, taking place May 11–13 at the Hilton West Palm Beach, Florida.
For founders, investors, corporates, and ecosystem leaders looking to be part of the conversation and the opportunities emerging from it, this is a moment worth marking on the calendar.
